Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 8, 2024
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective studyChangsong Qi, Xiaoyi Chong, Ting Zhou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2018
Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic ResistanceYilin Li, Xiaotian Zhang, Dan Liu, et al.Journal of Cancer Research and Clinical Oncology|February 15, 2022
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trialYanshuo Cao, Ming Lu, Yu Sun, et al.Clinical Colorectal Cancer|June 23, 2019
Clinicopathologic Characteristics of HER2-positive Metastatic Colorectal Cancer and Detection of HER2 in Plasma Circulating Tumor DNAQing Wei, Yinjie Zhang, Jing Gao, et al.Cancer Research and Treatment|December 23, 2022
Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker AnalysisTing Xu, Xicheng Wang, Ying Xin, et al.Oncotarget|October 28, 2016
Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC studyJie Li, Ming Lu, Zhihao Lu, et al.Journal of Experimental & Clinical Cancer Research : CR|March 31, 2019
Autophagy inhibition enhances PD-L1 expression in gastric cancerXiaojuan Wang, William K K Wu, Jing Gao, et al.Hepatology (Baltimore, Md.)|May 1, 2022
Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysisJun Zhou, Yongkun Sun, Wen Zhang, et al.British Journal of Cancer|April 17, 2025
Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancerJiarui Li, Min Tao, Lian Liu, et al.JCI Insight|January 17, 2023
Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatmentYumei Gao, Simeng Hu, Ruoyan Li, et al.Pageof 10